IGF2 and cancer: In detail, it has been demonstrated that IGF-1R signaling can contribute to malignant transformation and cancer growth and that the upregulation of IGF-1R and IGF-2 as well as the deregulation of their downstream signaling molecules increase the risk of cancer development and invasiveness [84].